tiprankstipranks
Trending News
More News >
Northwest Biotherapeutics (NWBO)
OTHER OTC:NWBO
US Market
Advertisement

Northwest Biotherapeutics (NWBO) Income Statement

Compare
505 Followers

Northwest Biotherapeutics Income Statement

Last quarter (Q1 2025), Northwest Biotherapeutics's total revenue was $375.00K, an increase of 32.04% from the same quarter last year. In Q1, Northwest Biotherapeutics's net income was $-19.61M. See Northwest Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.38M$ 1.93M$ 1.68M$ 1.00M$ 1.29M
Gross Profit
$ 1.38M$ -25.80M$ 135.00K$ -19.30M$ -32.35M
Operating Expenses
$ 67.89M$ 57.44M$ 68.86M$ 53.71M$ 54.26M
Depreciation and Amortization
$ 2.04M$ 1.73M$ 1.55M$ 586.00K$ 425.00K
EBITDA
$ -73.64M$ -55.34M$ -97.42M$ 184.72M$ -520.85M
Operating Income
$ -66.51M$ -55.51M$ -67.18M$ -52.70M$ -86.61M
Other Income/Expenses
$ -17.27M$ -7.09M$ -37.85M$ 231.83M$ -443.22M
Pretax Income
$ -83.78M$ -62.60M$ -105.03M$ 179.13M$ -529.82M
Net Income
$ -83.78M$ -62.60M$ -105.03M$ 179.13M$ -529.82M
Per Share Metrics
Basic EPS
$ -0.07$ -0.06$ -0.10$ 0.21$ -0.73
Diluted EPS
$ -0.07$ -0.06$ -0.10$ -0.06$ -0.73
Weighted Average Shares Outstanding
1.24B 1.12B 1.02B 873.52M 725.13M
Weighted Average Shares Outstanding (Diluted)
1.24B 1.12B 1.02B 1.01B 725.13M
Currency in USD

Northwest Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis